# A Trial of SHR0410 Injection in Hemodialysis Participants.

> **NCT03857568** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Pruritus

## Interventions

- **DRUG:** SHR0410
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03857568
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-15
- **Primary completion:** 2019-11-08
- **Final completion:** 2019-11-08
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857568, "A Trial of SHR0410 Injection in Hemodialysis Participants.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03857568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*